Keywords: medarex, aids, drug, clears, hurdle, mdx-240, bispecific

Medarex AIDS Drug Clears Hurdle

Article | 18 March 1996

Medarex' MDX-240, a bispecific antibody therapeutic for the treatment of HIV-infected patients, was well tolerated and provoked a transient increase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in